These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24176612)

  • 21. The Food and Drug Administration approves methylnaltrexone bromide for opioid-induced constipation.
    Lang L
    Gastroenterology; 2008 Jul; 135(1):6. PubMed ID: 18549816
    [No Abstract]   [Full Text] [Related]  

  • 22. Methylnaltrexone for opioid-induced constipation in patients with advanced illness: a 3-month open-label treatment extension study.
    Lipman AG; Karver S; Cooney GA; Stambler N; Israel RJ
    J Pain Palliat Care Pharmacother; 2011; 25(2):136-45. PubMed ID: 21657861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protocol for a randomised control trial of methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients (MOTION).
    Patel PB; Brett SJ; O'Callaghan D; Anjum A; Cross M; Warwick J; Gordon AC
    BMJ Open; 2016 Jul; 6(7):e011750. PubMed ID: 27412108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treating opioid-induced constipation with methylnaltrexone bromide.
    Kyle G
    Nurs Times; 2009 Feb 3-9; 105(4):25. PubMed ID: 19263773
    [No Abstract]   [Full Text] [Related]  

  • 25. Methylnaltrexone (Relistor) for opioid induced constipation.
    Med Lett Drugs Ther; 2008 Aug; 50(1292):63-4. PubMed ID: 18688204
    [No Abstract]   [Full Text] [Related]  

  • 26. Methylnaltrexone for opioid-induced constipation in a pediatric oncology patient.
    Kissling KT; Mohassel LR; Heintz J
    J Pain Symptom Manage; 2012 Jul; 44(1):e1-3. PubMed ID: 22770490
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
    Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
    Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
    Leppert W
    Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral methylnaltrexone for opioid-induced constipation.
    Yuan CS; Foss JF
    JAMA; 2000 Sep; 284(11):1383-4. PubMed ID: 10989399
    [No Abstract]   [Full Text] [Related]  

  • 30. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.
    Slatkin N; Thomas J; Lipman AG; Wilson G; Boatwright ML; Wellman C; Zhukovsky DS; Stephenson R; Portenoy R; Stambler N; Israel R
    J Support Oncol; 2009; 7(1):39-46. PubMed ID: 19278178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing opioid-induced constipation.
    Nursing; 2008 Jul; 38(7):55. PubMed ID: 18580669
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological treatment of constipation in palliative care.
    Clemens KE; Faust M; Jaspers B; Mikus G
    Curr Opin Support Palliat Care; 2013 Jun; 7(2):183-91. PubMed ID: 23478431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.
    Mori M; Ji Y; Kumar S; Ashikaga T; Ades S
    Int J Clin Oncol; 2017 Apr; 22(2):397-404. PubMed ID: 27628064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug approvals: '08 in review. Methylnaltrexone (Relistor).
    Laustsen G; Carrillo F; Johnson J; Smith C
    Nurse Pract; 2009 Feb; 34(2):31. PubMed ID: 19155882
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeted Novel Pharmacotherapy to Improve Outcomes in Opioid-Induced Constipation.
    Gupta A
    J Fam Pract; 2015 Nov; 64(11 Suppl 2):. PubMed ID: 26697546
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of methylnaltrexone to induce laxation in acutely injured patients with burns and necrotizing soft-tissue infections.
    Hewitt K; Lin H; Faraklas I; Morris S; Cochran A; Saffle J
    J Burn Care Res; 2014; 35(2):e106-11. PubMed ID: 23877147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Management of Opioid-Induced Constipation in Cancer and Advanced Illness: A Meta-Analysis.
    Jesuyajolu DA; Abubakar AK; Kowe T; Ogunlade S; Abioye AI; Tangeman J; Latuga N; Omotayo MO
    J Pain Symptom Manage; 2024 Apr; 67(4):e285-e297. PubMed ID: 38092261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging new therapeutic options for the management of opioid induced constipation.
    Kapoor S
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):98-9. PubMed ID: 20345211
    [No Abstract]   [Full Text] [Related]  

  • 39. Opioid-induced constipation.
    Wein S
    J Pain Palliat Care Pharmacother; 2012 Dec; 26(4):382-4. PubMed ID: 23216186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treating constipation in palliative care: the impact of other factors aside from opioids.
    Clark K; Byfieldt N; Dawe M; Currow DC
    Am J Hosp Palliat Care; 2012 Mar; 29(2):122-5. PubMed ID: 21606123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.